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Clinical reports have attributed the amelioration of chronic 
inflammatory skin disorders to the presence of certain poly-
unsaturated fatty acids (PUFA) in dietary oils. To test the 
hypothesis of a local modulatory effect of these PUFA in the 
epidermis, the basal diet of normal guinea pigs was supple-
mented with ethyl esters of either fish oil [rich in eicosapen-
taenoic acid (EPA) and docosahexaenoic acid (DHA)] or bor-
age oil [rich in gamma-linolenic acid (GLA)). Our data 
demonstrated that dietary oils influence the distribution of 
PUFA in epidermal phospholipids and the epidermal levels 
of PUFA-derived hydroxy fatty acids. Specifically, animals 
supplemented with ethyl esters of fish oil markedly incorpo-
rated EPA and DHA into epidermal phospholipids, which 
paralleled the epidermal accumulation of 15-hydroxyeicosa-
pentaenoic acid (15-HEPE) and 17-hydroxydocosahexaen-
oic acid (17-HDoHE). Similarly, animals supplemented with 
0 xygenated metabolites of arachidonic acid (AA) (20:4n-6) are known to generate mediators (eicosa-noids) of inflammatory reactions (1 ,2). The possi-bility that eicosanoids formed from AA (particu-larly the 5-lipoxygenase products) may be involved 
in the patho~enesis of inflammatory skin disorders has been re-
viewed (3 - 7J. Interestingly, a weak inhibitor of leukotriene B4 
(L TB4) synthesis has been described to alleviate the lesions of psoria-
sis (8,9), supporting the view that the inhibition of products of the 
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Abbreviations: 
AA: arachidonic acid 
DGLA: dihomogammalinolenic acid 
DHA: docosahexaenoic acid 
EPA: eicosapentaenoic acid 
GLA: gammalinolenic acid 
HOFA: hydroxyfatty acid 
IC: inhibitory concentration 
esters of borage oil preferentially incorporated dihomogam-
malinolenic acid (DGLA), the epidermal elongase product of 
GLA, into the epidermal phospholipids, which also was ac-
companied by epidermal accumulation of 15-hydroxyeicosa-
trienoic acid (15-HETrE) . By factoring the epidermal levels 
of the 15-lipoxygenase products and their relative inhibitory 
potencies, we evolved a measure of the overall potential of 
dietary oils to exert local anti-inflammatory effect. For exam-
ple, the leukotriene inhibition potentials (LIP) of both fish 
oil and borage oil were greatly enhanced when compared to 
controls. Thus, the altered profiles of epidermal 15-lipoxy-
genase products generated from particular dietary oils may be 
responsible, at least in part, for reported ameliorative effects 
of oils on chronic inflammatory skin disorders. J Invest Der-
matol 96:98-103, 1991 
lipoxygenase pathway (particularly L TB4) may be critical in the 
management of at least the inflammatory aspects of psoriasis. 
Excitement that other polyunsaturated fatty acids (PUFA), partic-
ularly those of the n-3 series (and their oxidative metabolites), can 
affect a variety of chronic and inflammatory diseases (10-13) has 
l~d to interest in the dietary intake of fish oil. The interest in psoria-
SIS'was accentuated because of an epidemiologic study of Eskimos in 
Greenland by Kromann and Green (14), which revealed a 20 times 
decrease in the estimated incidence in psoriasis when compared to a 
LA: linoleic ac id 
L T: leukotriene 
PUFA: polyunsaturated 'fatty acid 
13-HODE: 13-hydroxyoctadecadienoic acid 
15-HETrE: 15-hydroxyeicosatrienoic acid 
15-HETE: 15-hydroxyeicosatetraenoic acid 
12-HETE: 12-hydroxyeicosatetraenoic acid 
15-HEPE: 15-hydroxyeicosapentaenoic acid 
17-HDoHE: 17-hydroxydocosahexaenoic acid 
18:2n-6/20:5n-3/22:6n-3: designations of fatty acids. The first num. 
ber represents the number of carbons in a straight chain and the 
number following the colon indicates the number of methylene-
interrupted cis double bonds. The number after n indicates the 
number of carbon atoms from the methyl end of the acyl chain to 
the nearest double bond. 
0022-202X/91/S03.50 Copyright © 1991 by The Society for Investigative Dermatology, Inc. 
98 
VOL. 96, NO. I J ANUARY 1991 
Danish group. This report was followed by tests of tl:e possible 
efficacy of dietary fish oil ' in the management of psonaSIS, With 
varying degrees of success [ 15- 17). Simi~arly, reports are emerging 
of the clinic.al impro~ement of patients w ith atopic ec~ema afte.r or.al 
admimstratwn of pnmrose 011[18- 20]. a vegetable 01l that IS n ch m 
gammalinolenic (GLA) acid . D espite these emergin.g reports, the 
b iochemical mechamsms of these reported therapeutic effects have 
remained unclear. 
As a first step in elucidating the ro le ofPU FA in cutaneous biol-
ogy, we investigated whether a relationship e:" i~ts between the di-
etary intake of. fish~01 l (an n-3 PUFA, contauung predoim~ant~y 
eicosapentaenoic ac1d (EPA]) (20:5n-3) and docosahexaen01c acid 
(DHA) (22:6 n-3) , the intake ofbora~e oil (an n-6 PUFA containing 
linoleic acid) (18:2n-6) and gammalmolemc acid (GLA) (18:3n-6) 
fatry acids, and the in vivo generation of oxidative .a nt~-inflam.ma­
tory metabolites of these PUFA. To attam these objeCtives , gmnea 
pig diets were supplemented with ethyl ester concentrates of etther 
fis h o il (an n-3 PUFA) or borage otl (an n-6 PUFA). After 8 weeks, 
we determined 1) whether the PUFA constituents of each dietary 
oil are incorporated into distinct epidermal phospholipid pools; 2) 
w hether the incorporation into phospholipids is accompanied by 
th e generation and accumulation of in vivo epidermal 15-lipoxy-
genase products of the dietary PUFA; and 3) whether these metabo-
lites possess the abi lity to inhibit generation of proinflammatory 
L TB4 by rat basophilic leukemic (RBL-1) cel l line (a model ofL TB4 
generation) . 
MATERIALS AND METHODS 
Dietary Treatment M ale weanling H artley guinea pigs (Simon-
sen, n = 15) were housed individually at 22-24•c with a 12-h 
diurnal light cycle; deionized water (0.05% ascorbic acid) and diet 
were provided ad libitum. After acclimating for 2 weeks on a stan-
dard chow diet (Purina), the ammals were randomly assigned mto 
three groups and fed purified diets as des~ribed pr~viously [21,22). 
T hese three groups (n = 5 per group) vaned only 111 the type of 01l 
used in the diet, such that each dietary group received 1% safflower 
oil (providing> 1.5 cal% 18:2n-6) and either 5% hydrogenated 
coconut oil (control), 5% ethyl ester concentrate of GLA-ennched 
borage oil (+ GLA), or 5% ethyl ester concentrate of EPA- and 
DHA-enriched fish body oil(+ EPA/DHA). The fatty acid compo-
sition of the diets is shown in Table I. The diets were mixed in a 
crude, powdered form and stored under N 2 at -2o•c. As needed, 
the powdered form of the diet was mixed with 2% agar in water to 
produce a gel (stored under N 2 at 4 • C, w~ich was the form of tl:e 
die t provided to the ammals for consumptiOn. Dtets were penodt-
cally analyzed for auto-oxidation by checking fatty acid profiles. 
Fresh diet was provided daily after diets not consumed was re-
moved. Body weights were recorded 3 times per week throughout 
the study. There were no significant differences in the growth 
curves of the three groups and no macroscopical differences in the 
appearances of the animals. Thus, there were no indications of es-
sential fatty acid (EFA) deficiency in any of the dietary groups. After 
Table I. Polyunsaturated Fatty Acid Compositions of 
Dietary Oils• 
Fatty Acids Control +GLA +EPA/DHA 
LA (18:2n-6) 
GLA (1 8:3 n-6) 
DGLA (20:3n-6) 
AA (20:4-n-6) 
EPA (20:5-n-3) 
DHA (22:6n-3) 
[15.64)b [47.62l 
[39.48 
14.71 
0.35 
0.27 
1.40 
[26.42] 
[20.68] 
• mg/ 100 mg total PUFA fatty acids. Values are expressed as mg/100 mg of tota l 
PUFA. Control represents 5% hydrogenated cocon ut oi l pl us I% sa fflower oil ; + GLA 
represents 5% ethyl ester concentrate of borage oil plus 1% safflower oil and +EPA/ 
DHA represents ethyl ester concentrate of fish oi l plus I % saftlower oil. 
b Brackets represe nt major polyunsaturated fatty acids. 
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Figure 1. A typical chromatogram of hydroxy fatty acid standards separated 
using a system of MeOH (74%) and H 20 (acidified to pH 3.0 with acetic 
ac id) run isocratically from 0-60 min at flow rate of 1.0 ml / min . 
8 weeks on the experimental diets, the animals were sacrificed for 
analyses. 
Lipid Analysis Epidermal strips were taken from the guinea 
pig and homo genized as reported previously [22). A portion of 
the crude epidermal homogenate was used to quantitate protein 
concentration by a modified Lowry method [23). Lipids from a 
portion of the crude epidermal homogen.ate. ':"'ere extracted 
wi th CHC13:Me0H (2:1, v/v) (24) and the mdtvtdual phospho-
lipids fractionated by thin-layer chromatography on 0.25-~m 
silica gel G plates (Merck, Darmstadt, FDR) usmg 
CHCl3:MeOH:HOAc:H20) (50:37 .5:3.5:2, v jv jv jv) (25,26). 
The individual phospholipids were visualized under UV light after 
spraying with 0 .2% 2', 7'-dichlorofluorescein in ethanol. The re-
spective bands were eluted from the st!tca ·gel and dned under N 2 gas 
after a known concentration of methylheptadecanoate was added as 
an internal standard to determine the relative contribution of fatty 
acids from each phospholipid class. The fatty acid profiles from the 
individual phospholipids were determined by gas chromatography 
after transmethylation in 6% methanolic HCl (22). The gas cluo-
matograph (Hewlett-Packard model 5730A) was equipped with a 
DB-225 fused silica capillary column (50% cyanopropylphenyl, 
0 .15-mm film thickness, 30 m X 0.25 mm i.d.; J &W Scientific, 
Rancho Cordova, CA). Hydrogen (36 em/sec) was used as the car-
rier gas, th e oven was run isothennically at 200°C, and detection 
was performed by fl ame ionization detector (FID) . 
Hydroxy fatty acids from the epidermal homogenate were ex-
tracted with ice-cold CHC13:MeOH (2:1, v jv) after acidification to 
pH 3.0. The profi les were determined by reverse phase-high per-
formance liquid chromatography (RP-HPLC) using a Beckman 5 
J..l.m octadecylsilica (ODS) column (25 em X 4.6 J..l.m i.d., Beckman), 
which was run isocraticall y at a flow rate of 1.0 ml/ min on a Beck-
man system e~uipped with Model 100A/110A pumps and a 421 
Controller (27J. The separated hydroxy fatty acids were monitored 
at 237 nm with a Beckman Model 165 Variable Wavelength De-
tector. Quantitation was determined wi th external standards of 13-
h ydroxyoctadecadienoic acid ( 13-H 0 DE), 15-hydroxyeicosatrien-
o ic acid (1 5-HET rE), 15-hydroxyeicosatetraenoic acid (15-HETE), 
12-hydroxyeicosatetraenoic acid (1 2-HETE), 15-hydroxyeicosa-
pentaenoic acid (15-HEPE), and 17-hydroxydocosahexaenoic acid 
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Table II. Effects of Diets Enriched with Ethyl Ester Concentrates of n-6 and n-6 PUFA on Distribution of Fatty Acids in 
Phosphatidylcholine and Phosphatidylethanolamine• 
Phosphatidylcholine (PC) Phosphatidylethanolamine (PE) 
PUFA Control +GLA +EPA/DHA Control +GLA +EPA/DHA 
t8:2n-6 tt .60 + .80• 9.96 + .29··b 8.54 + .S4b 11.64 + .66• 9.88 + 1.03• t2.43 + 1.74• 
20:3n-6 0.26 + .02• 1.27 + .Q9b 0.4t+.15• 0.90 + .2t• 2.85 +.3th 1.46 + .31• 
20:4n-6 2.45+.t7• 3.77 + .17b 2.45 + .tO• 11.30 + 1.02• 14.26 + 1.23• 4.46 + 1.3Qb 
20:5n-3 tr' tra 1.32 + .40b 0.11 + .09• tr' 2.59+.t4b 
20:6n-3 tr' tr' 0.36 + .03b tr' tr' 2.49 + .23b 
• mg/ 100 mg total phospholipid fatty acids. Values arc expressed as mg/100 mg total phospholipid fatty acids and represent means± SEM (n = 3). Values not sharing a common 
superscipt letter are significantly different (p < 0.05). lr indicates levels are not detectable. Sec footnote to Table I for key to diet abbreviations. 
(17-HDoHE) (Cayman Chemicals, Philadelphia, PA) . A representa-
tive chromatogram of the hydroxy fatty acid standards as separated 
by this HPLC system is depicted in Fig 1. 
Preparation of 15-Lipoxygenase Products of Polyunsatu-
rated Fatty Acids by Guinea Pig Epidermal Homogenates 
To obtain and evaluate the putative anti-inflammatory potentials 
of 15-lipoxygenase products that are generated from dietary poly-
unsaturated fatty acids (PUFA), the respective 15-lipoxygenase 
products of AA (20:4n-6), DGLA (20:3n-6), EPA (20:5n-3), and 
DHA (22:6n-3) were first synthesized by incubating each precursor 
fatty acid (NuChek Prep, Inc. Elysian, MN) with soybean lipoxi-
dase (Sigma, St. Louis, MO) (22] . The crude products were purified 
by HPLC using a silica column (5 Ji.m, Ji.Porosil; Beckman) and the 
solvent system of hexane/ethanol/acetic acid (983/16/1; vfv/v) 
and quantitated via spectrophotometric analyses and by co-chroma-
tography with authentic standard (Biomol; Philadelphia, PA). The 
identity of each 15-lipoxygenase product denved from the mcuba-
tion of each respective PUFA and soybean lipoxygenase was con-
firmed by reverse-phase (RP)-HPLC and gas chromatography/ 
mass spectrometry (GC/MS), as described previously. 
Effects of Epidermal 15-Lipoxygenase Metabolites of Di-
etary PUFAon RBL-1 LTB4 Generation We tested the effects 
of varying concentrations of each of the generated hydroxy fatty 
acids on L TB4 generation by rat basophilic leukemia cells (RBL-1), 
as published previously [22]. Specifically, RBL-I cells were place~ 111 
buffer (50 mM phosphate, pH 7.4, 1 mM EDTA) at a c?ncentratlon 
of 3 X 107 cells/ml and then homogenized by somcauon. The 
crude homogenate was centrifuged at 10,000 g to obtain a superna-
tant containing the 5-lipoxygenase activity. Supernatant enzyme 
preparations were pre-incubated with 2 mM CaC12 and varying 
concentrations (0-50 Ji.M) of either 15-HETrE, 15-HEPE, or 17-
HDoHE at 37oC for 10 min. Reactions were initiated by the addi-
tion of [1-14C] 20:4n-6 (DuPont, New England Nuclear Products 
Division, Boston, MA) at a final concentration of 20 Ji.M and 0.2 
Ji.Ci. Incubations continued for an additional 20 min and were then 
terminated by placement in ice, followed by acidification to pH 3.0. 
The incubation products were extracted with CHC13:MeOH (2:1, 
v /v) and the conversion of[1-'4C] 20:4n-6 into 14C-LTB4 and 14C-
5-HETE was ascertained by a gradient reverse-phase- HPLC sys-
tem using a modified solvent system of methanol/water (0.08% 
HOAc, pH 6.2), according to Henke et al (28]. 
Statistical Analysis Data were subjected to one-way analysis of 
variance by Student t test using the Bonferroni transformation for 
comparisons between three means. The upper level of significance 
chosen was p < 0.05. 
RESULTS 
Incorporation of Dietary PUFA into Individual Epidermal 
Phospholipids The fatty acid profiles of the phospholipids (Ta-
bles II, III) reflected the fatty acid contents of the oils ingested 
(Table I) by the three groups. The epidermal phospholipids of the 
ammals fed the fish oil (EPA/DHA)-enriched diet had higher levels 
of the n-3 fatty acids than those animals fed safflower (LA)-enriched 
(control) or the borage oil (GLA)-enriched diets. The levels of EPA 
(20:5n-3) in the epidermal phospholipids of the fish oil (EPA/ 
DHA)-supplemented animals were significantly high (p <0.05) in 
the ~hosphaudylcholine (PC) and phosphatidylethanolamine (PE) 
fractwns (Table II). In contrast, the incorporation of EPA/DHA 
was negligible ~n the phosphatidylserine (PS) and phosphatidylino-
Sltol (PI) fractions (Table III). Interestingly, the levels of EPA/ 
DHA 111 fish ml-fed animals were higher in PE than in PC (Table 
II), indicating a special role of this phospholipid in epidermal PUFA 
homeostasis. 
. Similarly, the_ animals fed the GLA-enriched borage oil revealed 
h1gh mcorporat1on of DGLA (20:3n-6), the elongation product of 
GLA, 1nto the ep1dermal phospholipids, when compared with the 
epidermal phospholipids of the animals fed either safflower oil (LA-
ennched) or fish ml (EPA/DHA-enriched) diets. The level of 
DGLA (like EPA/DHA) was higher in the PE than in the PC 
fraction ('~able II), further indicating the importance of PE for 
mcorporatmg d1etary DGLA and EPA/DHA. Additionally, unlike 
the n~3 PUFA (EPA/DHA), the DGLA, an n-6 PUFA, was notably 
h1&h Ill PI_ and PS. This is interesting, as these latter two phospho-
lipids are lmked to cutaneous s1gnal transduction mechanisms. The 
role of DGLA and/or its metabolites in cqtaneous signal transduc-
tiOn mechamsms remains to be determined. 
Table III. Effects of Diets Enriched with Ethyl Ester Concentrates of n-6 and n-3 PUFA on Distribution of Fatty Acids in Epidermal 
Phosphatidylserine and Phosphatidylinositol• 
Phosphatidylserine (PS) Phosphatidylinositol (PI) 
PUFA Control +GLA +EPA/DHA Control +GLA +EPA/DHA 
18:2n-6 4.45 + .57• 4.20 + .32• 3.79 + .65• 4.50 + .60• 4.52 + .37• 5.16 + .87• 
20:3n-6 0.71 + .20• 2.50 + .22b 0.98 + .t9• 0.64 + .04b 2.70 + .26b 1.22 + .11• 
20:4n-6 1.91 + .31• 1.92 + .29• 1.36 + .32• 6.16 + .79• 7.30 + 1.30• 6.30 + .88• 
20:5n-3 0.22 + .t4• tr' 0.25 +.lOb tr' tr' 0.64 + .34• 
20:6n-3 tr' tr' 0.72+ .19b tr' tr' 0.84 + .33• 
• Values arc expressed as mg/100 mg total phospholipid fatty acids and represent means± SEM (n = 3). Values not sharing a common superscipt letter are significantly different 
(p < 0.05). tr indicates level s are not detectable. Sec footnote to Table I for key to diet abbreviations. 
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Table IV. Effect of Diets Enriched with Ethyl Ester Concentrates of n-6 and n-3 Fatty Acids on In Vivo Generation of 
· Epidermal Hydroxy Fatty Acids• 
Precursor Hydroxy 
(ng/ mg protein) 
PUFA Fatty Acids Control +GLA +EPA/ DHA 
LA (18:2n-6) 13-HODE 2.73 + .08' 2.12 + .33' 1.41 + .14b 
DGLA (20:3n-6) 15-HETrE 0.07 + .01' 0.27 + .01b 0.07 + .01' 
AA (20:4n-6) 15-HETE 0.67 + .02' .75 + .08b 0.58+.10' 
AA (20:4n-6) 12-HETE 0.14 + .02' 0.19 + .03b 0.51 + .07' 
EPA (20:5n-3) 15-HEPE tr' tr' 0.46 + .06b 
DHA (22:6n-3) 17-HDoHE tr' trb 0.08 + .01 ' 
• Values are means ± SEM (n = 3). Values not sharing a co mmon superscipt letter are sign ifican tly different (p < 0.05). trindicatcs levels arc not detectable. See footnote to Table I 
for ·key to diet abbrev iations. 
The two predominant PUFA in epidermal phospholipids, lino-
leic acid (LA) (18:2n-6) and arachidonic acid (AA) (20:4n-6) are also 
preferentially incorporated into PE. A notable effect of guinea pig 
diet supplementation with fish oil (EPA/DHA) is the increased 
incorporation of DGLA into the epidermal phospholipids when 
compared to the safflower oil-fed (coimol) animals (Table II). Al-
though the mechanism for this .n-3 PUFA-induced increase of 
DGLA is not immediately clear, the finding nonetheless suggests a 
possible cooperative effect of n-3 and n-6 PUFA. One possibili ty is 
the inhibition of .15 desaturase activity (the enzyme that catalyzes 
the transformation of DGLA into AA) by increased ingestion of 
EPA/DHA (n-3 PUFA)-containing oils, which thereby will elevate 
epidermal DGLA. 
Epidermal Hydroxy Fatty Acids Analyses of endogenous epi-
dermal hydroxy fatty acids revealed that they reflect the increased 
incorporation of the respective PUFA from the dietary oils into 
epidermal phospholipids (Table IV). For instance, 13-HODE and 
15-HETE, the most abundant hydroxy fatty acids, are 15-lipoxy-
genase products of LA and AA, respectively. The differences in the 
levels of 13-HODE and 15-HETE between the dietary groups are 
consistent with the differences in the levels of LA and AA in the 
epidermal phospholipids of the groups. 
The most significant changes in epidermal hydroxy fatty acid 
levels were those of 15-HETrE, 15-HEPE, and 17-HDoHE, all 
15-lipoxygenase products of DGLA, EPA, and DHA, respectively. 
Interestingly, the EPA/DHA-supplemented animals has signifi-
cantly elevated levels of 15-HEPE and 17-HDoHE, whereas the 
GLA-supplemented animals had significantly elevated levels of 15-
HETrE when compared to safflower-fed (control) animals. As with 
13-HODE and 15-HETE, the levels of 15-HEPE and 15-HETrE 
correlate with the levels of incorporated substrate fatty acids in the 
epidermal phospholipids .. 
Additionally, analyses of the epidermal extracts revealed the pres-
ence of 12-HETE, a 12-lipoxygenase product of AA. In contrast to 
the 15-lipoxygenase products, the level of 12-HETE (S/ R) did not 
correlate with the levels of its substrate (AA) in any of the individual 
epidermal phospholipid classes . For instance, the level of total 12-
HETE (S/R) in the epidermis of the fish oil (EPA/DHA)-supple-
mented group was significantly elevated when compared with the 
level of 12-HETE (S/R) in the GLA- and LA-enriched dietary 
groups, which incorporated higher levels of AA into the phospho-
lipids (Tables II, III). 
Inhibition of LTB4 Synthesis by 15-Lipoxygenase Prod-
ucts Results in Fig 2 demonstrate that epidermal 15-lipoxygenase 
products exert varying dose-dependent inhibitory activities on 
Ca++-ionophore induced-RBL-1 cell-5-l ipoxygenase activity . The 
IC50 for 15-HETrE (a metabolite of DGLA) was 18 ,uM and is the 
most potent of the four tested monohydroxy fatty acids. The IC50 of 
15-HEPE and 17-HDoHE (both 15-lipoxygenase metabolites of 
EPA and DHA) were intermediate (25 ,uM and 28 ,uM, respec-
tively). In contrast, the IC50 for 15-HETE (a metabolite of AA) was 
37 ,uM, indicating that it is apparently the least potent of the hy-
droxy fatty acids tested. Overall, the ability o( the 15-lipoxygenase 
products to inhibit RBL-1 -5-Iipoxygenase activity follows the 
order 15-HETrE > 17-HDoHE > 15-HEPE > 15-HETE. 
DISCUSSION 
Our data indicate a strong sequential relationship between the 
PUFA constituents of the dietary oils, the distribution of constitu-
ent PUFA in epidermal phospholipids, the levels of 15-lipoxygen-
ase products in the epidermis, and the _potential of these epidermal 
products to inhibit the local productiOn of mflammatory leuko-
trienes . Specifically, results from Tables II and III demonstrate the 
effects of dietary PUFA composttlon (Table I) on the PUFA profiles 
of individual epidermal phospholipids. For example, dietary sup-
plementation with fish oil resulted in the incorporation of EPA/ 
DHA into guinea pig eptdermal ph~sphohp.tds, whereas dtetary 
supplementation with borage 01! (ennched wtth GLA) resulted 111 
the incorporation of higher levels of DGLA (the elongase produce 
of GLA). These results are in agreement with a past study by our 
laboratory showing a similar link between dtetary PUFA and the 
distribution of PUFA 111 eptdermal ltptds (29). 
The data in Table IV indicated that the levels of 15-lipoxygenase 
products in epidermal extracts reflect the levels of their correspond-
ing PUFA precursors 111 the ept~ermal phosph~ltptds . For example, 
in the fish oil-supplemented ammals, the 15-hpoxygenase product 
of EPA (15-HEPE, 0.46 ng/mg protein) increased from non-de-
tectab le levels to levels that are similar in magnitude to the 15-li-
poxygenase product of AA (15-HF.TE, 0.58 ng/mg protein), wher-
eas the 15-lipoxygenase product ofDHA (17-HDoHE, 0.08 ng/mg 
protein) increased from non-detectable levels to detectable levels. 
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Similarly, in the borage oil-supplem ented animals, the level of 15-
H ETrE (the 15-lipoxygenase product of D G LA) was significantly 
elevated (0 .27 n g/m g protein) from non-detectable levels. 
Because linking the levels of epidermal1 5-lipoxygenase products 
to their potential to inhibit localleukotriene synthesis is not easily 
m easurable fro m in vivo param eters, w e derived an arbitrary factor 
named " leu kotriene inhibition potential" (LIP). This factor deter-
mines the potential of epidermal 15-lipoxygenase products from 
specific PUFA to inhibit the local generation of leukotrienes. As 
demonstrated from our studies (Fig 2) the validity of LIP determina-
tion depended on the abili ty of the 15-lipoxygenase products to 
inhibit proinfl ammatory LTB4 generation by 5-lipoxygenase en-
zym e from RBL-homogenate. By dividing the epidermal level of 
each individual1 5-lipoxygenase by its IC 50 , a contributio n for each 
individual1 5-lipoxygenase product can be derived. By summing up 
the individual contributions, one can establish an overall LIP for 
each dietary oil. For example, both the fish oil- and borage oil-sup-
plem ented animals (as shown in Fig 3) revealed significant LIP 
increase w hen compared with control animals fed safflower oil-
supplem ented diet. Furthermore, the LIP of the fish oil-supple-
m ented animals (0.038) is approximately 73o/o higher than the LIP 
of the control animals (0 .022) . This increase w as largely due to 
contributio ns of EPA-derived 15-HEPE and DHA-derived 17-
HDoHE. Similarly, the LIP of the borage oil-supplemented animals 
(0 .0 37) is approxim ately 68 o/o higher than the LIP of the control 
animals, largely due to the contribution of DGLA-derived 15-
H ETrE. These es timations imply that the level of 15-lipoxygenase 
products in the epidermis, particul arly those derived from certain 
dietary PUFA, can greatly influence locally-derived, cutaneous 
anti-inflammatory products. The level in the tissue can in turn 
suppress the generation of leukotrienes in the skin. It is therefore 
reasonable to speculate that by suppressing localleukotriene synthe-
sis, one can diminish furth er recruitment of leukocytes to an area of 
cutaneous inflammation. 
Results.fro m this study extend our previous observations [29) , as 
well as those of other investigators, that the constituent PUFA in 
the diet can have profound effects on th e levels and spectrum of 
tissue eicosanoids. A significant aspect of our findin gs is that constit-
uent PU FA in dietary oils can be transfo rmed enzym atically by 
epidermis into " putative" anti-inflammatory products. Thus, it is 
reasonable to specul ate that dietary PUFA, ~n the o ne ha~d , can 
alter the epidermal environment such that the mfiltratton of mflam-
m atory leukocytes to the tissue is markedly reduced and , on the 
o ther hand , can serve pharmacologically during an inflammatory 
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Figure 3. Leukotriene inhibition potential (LIP) of hydroxy fatty acids 
generated fro m dietary PUFA. Each vertica l box, control,+ GLA, or + EPA/ 
DHA, represents inhibitory potentials of diets containi ng AA, GLA, or 
EPA/ DHA, respectively. 
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condition to sup£ress the symptoms of chronic inflammatory skin 
disorders [15- 20J . As data from these studies have established a link 
between dietary oils, the generation of anti-inflammatory local 
products, and their abiliry to suppress the generation of pro-inflam-
m atory leukotrienes , future studies should focus on evolving dietary 
formulations to m aximize epiderm al levels of PUFA. Implications 
o f these findings reach beyond the scope of cutaneous disorders to a 
variety o f chronic inflammatory diseases in which eicosanoids may 
pl ay an important role. 
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